Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +902.8% | +1516.1% | 2 / 3 | -88.3% | -2.83 pp | +28.45 pp | -1.8% | 0.00 | — | 67,2 | −88,3% | 19,4 | +902,8% | — | 5.10 | — |
| Pts | 12 | 12 | 8 | 0 | 4 | 12 | 0 | 12 | 8 | |||||||
Valuation annotation:Price: 6.360 (close price on 2026-10-16)EPS (TTM): −209,8
Financial charts
1.Revenue & growth
VND bn67,2Q2/26
1.Revenue & growth
VND bn67,2Q2/26
2.Profit & growth
VND bn18,2Q2/26
3.Profit mix (Penman)
VND bn-1,69Q2/26
4.Margins & cost structure
%-0.7%Q2/26
5.Returns & cash cycle
% · days-21.7%Q2/26
6.Earnings quality & cash
VND bn249Q2/26
7.Asset structure
VND bn203Q2/26
8.Funding & debt health
VND bn · times203Q2/26
9.Revenue backlog
VND bn5,01Q2/26
10.Valuation
times · %-22,0×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %1.198Q2/26
Adjusted EPS growth, latest quarter
843%
Average adjusted EPS growth, 3 quarters
16,0× higher
Quarters at 25%+ growth
2/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26